Financial Statements — SPTX
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Cash & Equivalents | 64.22 | 52.91 |
| Short-term Investments | 209.09 | 129.70 |
| Total Current Assets | 282.18 | 188.34 |
| Property, Plant & Equipment | 0.36 | 0.39 |
| Total Non-current Assets* | 159.51 | 39.33 |
| Total Assets | 441.68 | 227.67 |
| Accounts Payable | 5.71 | 4.79 |
| Total Current Liabilities | 15.67 | 14.22 |
| Total Non-current Liabilities* | 3.41 | 3.74 |
| Total Liabilities | 19.08 | 17.97 |
| Retained Earnings | (202.12) | (139.52) |
| Total Stockholder Equity | 422.60 | (115.62) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 |
|---|
| Research & Development | 24.62 | 21.43 |
| Selling, General & Admin | 41.19 | 6.11 |
| Total Operating Expenses | 65.81 | 27.54 |
| Operating Income | (65.81) | (27.54) |
| Pretax Income | (62.35) | (24.89) |
| Tax Provision | 0.25 | 0.52 |
| Net Income | (62.60) | (25.41) |
| Basic EPS | (1.78) | (10.34) |
| Diluted EPS | (1.78) | (10.34) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Operating Cash Flow | (26.14) | (20.17) |
| Capital Expenditures | 0.00 | 0.00 |
| Free Cash Flow* | (26.14) | (20.17) |
| Investing Cash Flow | (203.50) | 27.85 |
| Financing Cash Flow | 240.93 | (0.78) |
* Derived from reported values
Dividends Per Share
(USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Dividends Per Share | 0.00 | 0.00 |